Velpatasvir is an NS5A inhibitor and direct-acting antiviral agent used in combination therapy to treat chronic Hepatitis C infection. Laboratories utilize reference standards of this drug, along with… Read more
![Chemical structure of Methyl ((S)-2-((2S,4S)-2-(4-(2-((2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1493768-22-1-Methyl-S-2-2S4S-2-4-2-2S5S-1-methoxycarbonyl-L-valyl-5-methylpyrrolidin-2-yl-111-dihydroisochromeno4367naphtho12-dimidazol-9-yl-1H-imidaz.png&w=3840&q=75)
![Chemical structure of Methyl ((S)-2-((2S,4S)-2-(5-(2-((2S,5S)-1-((methoxycarbonyl)-D-valyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FMethyl-S-2-2S4S-2-5-2-2S5S-1-methoxycarbonyl-D-valyl-5-methylpyrrolidin-2-yl-111-dihydroisochromeno4367naphtho12-dimidazol-9-yl-1H-imidazol-2-yl-4-met.png&w=3840&q=75)


![Chemical structure of rel-1,1-Dimethylethyl (2R,4R)-2-[5-[6a,11-dihydro-2-[(2R,5R)-1-[(2R)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4′,3′:6,7]naphth[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinecarboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2714832-16-1-rel-11-Dimethylethyl-2R4R-2-5-6a11-dihydro-2-2R5R-1-2R-2-methoxycarbonylamino-3-methyl-1-oxobutyl-5-methyl-2-pyrrolidinyl2benzopyrano4367.png&w=3840&q=75)
![Chemical structure of tert-Butyl (2S,4S)-2-(5-(2-((2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidin-2-yl)-1,4,5,11-tetrahydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl)-4-(methoxymethyl)pyrrolidine-1-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1378391-44-6-tert-Butyl-2S4S-2-5-2-2S5S-1-methoxycarbonyl-L-valyl-5-methylpyrrolidin-2-yl-14511-tetrahydroisochromeno4367naphtho12-dimidazol-9-yl-1H-i.png&w=3840&q=75)




















Velpatasvir is an NS5A inhibitor and direct-acting antiviral agent used in combination therapy to treat chronic Hepatitis C infection. Laboratories utilize reference standards of this drug, along with its impurities, metabolites, and stable isotope labelled compounds, for rigorous analytical testing and quality control. These highly characterized materials are essential for impurity profiling, allowing for the precise identification and quantification of process-related and degradation products that may affect drug potency or safety. Stable isotope labelled versions, which behave chemically like the parent molecule while providing a distinct mass for detection, serve as critical internal standards for mass spectrometry and chromatographic assays. By using these qualified materials for method validation and stability studies, researchers ensure compliance with regulatory standards and maintain consistent product quality throughout the drug development lifecycle.